Nuvilex Inc.

PMCB Healthcare Biotechnology

In the quarter to July 2026, EPS grew 56.1% and free cash flow grew 60.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.34 0.02 −5.56%
Market cap
$3.8M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Apr '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 Apr '19 Apr '18 Apr '17
Total current assets
37.42 22.38 50.44 68.15 85.49 2.28 1.04 0.65 1.28 3.54
Total non-current assets
9.33 32.79 9.46 5.13 5.13 5.13 5.13 5.13 5.13 5.13
Total Assets
46.75 55.17 59.90 73.28 90.62 7.40 6.17 5.78 6.41 8.67
Total current liabilities
0.83 2.91 7.42 0.59 0.70 0.72 1.03 0.74 0.64 0.58
Total non-current liabilities
12.63 0.36 24.84 — — — 0.05 — — —
Total liabilities
13.46 3.28 32.26 0.59 0.70 0.72 1.08 0.74 0.64 0.58
Common Equity (Total)
33.30 51.89 27.65 72.69 89.92 6.68 5.09 5.04 5.77 8.09
Shareholders Equity (Total)
33.29 51.89 27.65 72.69 89.92 6.68 5.09 5.04 5.77 8.09
Total Debt
— 0.03 — — — 0.05 0.08 — — —

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Oct 2026